Shasqi competitorsClear all

Shasqi's top competitors include Pionyr Immunotherapeutics, Z Factor, Aytu BioScience and Mymetics.
Shasqi
Shasqi
Shasqi is a company focused on developing cancer treatments.
Pionyr Immunotherapeutics
Pionyr Immunotherapeutics
Pionyr Immunotherapeutics discovers and develops biologic drugs that fine-tune natural immune responses to increase immune defenses for diseases.
Z Factor
Z Factor
Z Factor Limited is a drug discovery company.
Aytu BioScience
Aytu BioScience
Aytu BioScience is initially concentrating on prostate cancer, male sexual dysfunction and male infertility and will expand into other urological indications through acquisition or licensing of approved, commercialized products and late-stage development assets.
Mymetics
Mymetics
Mymetics develops nex-generation prophylactic vaccines for infectious diseases.
Founding Date
Founding Date
2018
Founding Date
2015
Founding Date
2014
Founding Date
N/A
Founding Date
1994
Type
Type
Private
Type
Private
Type
Private
Type
Public
Type
Public
Tags
Locations
Locations
San Francisco, US HQ
Locations
South San Francisco, US HQ
Locations
Babraham, GB HQ
Locations
Englewood, US HQ
Locations
Epalinges, CH HQ
Leiden, NL
Employees
Employees
N/A
Employees
477% increase
Employees
4
Employees
537% decrease
Employees
5
Valuation ($)
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
161.6 m
Valuation ($)
14.4 m
Alexa Website Rank
Alexa Website Rank
418403
Alexa Website Rank
409734
Alexa Website Rank
379840
Alexa Website Rank
310059
Alexa Website Rank
N/A
Employee Rating
Employee Rating
N/A
Employee Rating
N/A
Employee Rating
N/A
Employee Rating
1.9
Employee Rating
2.5

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$3.7m (FY, 2018)
Revenue (est.)
€653k (FY, 2019)
Net income
Net income
N/A
Net income
N/A
Net income
N/A
Net income
($10.2m) (FY, 2018)
Net income
(€4.2m) (FY, 2019)

Funding

Latest funding round
Latest funding round
$ 10m (8 months ago)
Latest funding round
$ 275m (18 days ago)
Latest funding round
$ 9.1m (about 3 years ago)
Latest funding round
N/A
Latest funding round
N/A
Total funding raised
Total funding raised
$ 10.1m
Total funding raised
$ 345m
Total funding raised
$ 9.1m
Total funding raised
N/A
Total funding raised
N/A
For sources of this data, please see the company profile

View company profiles

Pionyr Immunotherapeutics
HQ
South San Francisco, US
Employees
47↑ 7% increase

Pionyr Immunotherapeutics discovers and develops biologic drugs that fine-tune natural immune responses to increase immune defenses for diseases.

View company
Z Factor
HQ
Babraham, GB
Employees
4

Z Factor Limited is a drug discovery company.

View company
Aytu BioScience
HQ
Englewood, US
Employees
53↓ 7% decrease

Aytu BioScience is initially concentrating on prostate cancer, male sexual dysfunction and male infertility and will expand into other urological indications through acquisition or licensing of approved, commercialized products and late-stage development assets.

View company
Mymetics
HQ
Epalinges, CH
Employees
5

Mymetics develops nex-generation prophylactic vaccines for infectious diseases.

View company